Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  IDEXX Laboratories    IDXX

IDEXX LABORATORIES (IDXX)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets
The feature you requested does not exist. However, we suggest the following feature:

IDEXX Laboratories : to Present at Two Conferences

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/19/2018 | 03:51pm CET

WESTBROOK - IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, will participate in two upcoming conferences:

Monday, February 26, 1:25 pm EST - Brian McKeon, Executive Vice President and Chief Financial Officer, and Jay Mazelsky, Executive Vice President, will present at the Bank of America Merrill Lynch Animal Health Summit, New York, New York.

Monday, March 5, 4:00 pm EST - Brian McKeon, Executive Vice President and Chief Financial Officer, will present at the 39th Annual Raymond James Institutional Investors Conference, Orlando, Florida.

Individuals can access the live audio webcasts of the presentations through links on the IDEXX website, www.idexx.com/investors. An archived edition of the presentations will be available via the same link.

About IDEXX Laboratories

IDEXX Laboratories, Inc. is a member of the S&P 500 Index and is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. IDEXX products enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and build more economically successful practices. IDEXX is also a worldwide leader in providing diagnostic tests and information for livestock and poultry and tests for the quality and safety of water and milk. Headquartered in Maine, IDEXX Laboratories employs more than 7,000 people and offers products to customers in over 175 countries.

Contact:

Kerry Bennett

Tel: 1-207-556-8155

(C) 2018 Electronic News Publishing, source ENP Newswire

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on IDEXX LABORATORIES
03:51pIDEXX LABORATORIES : to Present at Two Conferences
AQ
02/16IDEXX LABORATORIES : DE MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDIT..
AQ
02/15IDEXX LABORATORIES : to Present at Two Conferences
PR
02/09IDEXX LABORATORIES : Advances Power of SediVue Dx With Latest Software Update
AQ
02/07IDEXX LABORATORIES : introduces new software update for SediVue Dx
AQ
02/05GLOBAL VETERINARY DIAGNOSTIC IMAGING : Veterinary Diagnostic Imaging Market Over..
AQ
02/05IDEXX LABORATORIES : Announces Fourth Quarter and Full Year 2017 Results
AQ
02/05IDEXX LABORATORIES : Advances Power of SediVue Dx with Latest Software Update
PR
02/02VETERINARY DIAGNOSTIC IMAGING MARKET : Veterinary Diagnostic Imaging Market Over..
AQ
02/01IDEXX LABORATORIES : IDEXX Laboratories, Inc. to Host Earnings Call
AC
More news
News from SeekingAlpha
02/15IDEXX LABORATORIES : Take The Money And Run 
02/02Cramer Dives Into Big Tech Earnings - Cramer's Mad Money (2/1/18) 
02/01IDEXX Laboratories (IDXX) CEO Jonathan Ayers on Q4 2017 Results - Earnings Ca.. 
02/01IDEXX Laboratories Q4 revenues up 14%; updates guidance 
02/01IDEXX Laboratories misses by $0.03, beats on revenue 
Financials ($)
Sales 2018 2 223 M
EBIT 2018 491 M
Net income 2018 364 M
Debt 2018 617 M
Yield 2018 -
P/E ratio 2018 44,86
P/E ratio 2019 37,89
EV / Sales 2018 7,44x
EV / Sales 2019 6,66x
Capitalization 15 916 M
Chart IDEXX LABORATORIES
Duration : Period :
IDEXX Laboratories Technical Analysis Chart | IDXX | US45168D1046 | 4-Traders
Technical analysis trends IDEXX LABORATORIES
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 11
Average target price 201 $
Spread / Average Target 10%
EPS Revisions
Managers
NameTitle
Jonathan W. Ayers Chairman, President & Chief Executive Officer
Brian P. McKeon Chief Financial Officer, Treasurer & Executive VP
Ken Grady Chief Information Officer & Vice President
Rebecca M. Henderson Independent Director
Bill T. End Lead Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
IDEXX LABORATORIES13.99%15 826
MEDTRONIC PLC1.37%110 797
STRYKER CORPORATION0.90%58 471
BECTON, DICKINSON AND COMPANY2.75%50 458
BAXTER INTERNATIONAL2.15%35 975
ESSILOR INTERNATIONAL-5.39%29 884